To Determine the Financial Imapct of Introducing Sc Rituximab (MABTHERA) vs. Currently Used Iv Rituximab (MABTHERA) on the Budgets of Different Hospitals Across the Kingdom of Saudi Arabia (KSA)

Value in Health - United Kingdom
doi 10.1016/j.jval.2017.08.152
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV


Related search